| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,578 | 2,750 | 3,401 | 3,731 | | Selling General and Administrative | 5,186 | 1,536 | 1,962 | 1,410 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,425) | (4,286) | (5,363) | (5,141) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6 | 36 | 68 | 166 | | Earnings Before Interest And Taxes | (3,413) | (4,250) | (5,295) | (4,975) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,413) | (4,250) | (5,295) | (4,975) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,413) | (4,250) | (5,295) | (4,975) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,413) | (4,250) | (5,295) | (4,975) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,413) | ($4,250) | ($5,295) | ($4,975) |
|
0.31% Nasdaq 
0.05%
Income Statement
